- Home
- NEHC vs TRAW Comparison
NEHC vs TRAW Comparison
Compare NEHC & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEHC
- TRAW
- Stock Information
- Founded
- NEHC 2023
- TRAW 1998
- Country
- NEHC United States
- TRAW United States
- Employees
- NEHC N/A
- TRAW N/A
- Industry
- NEHC
- TRAW
- Sector
- NEHC
- TRAW
- Exchange
- NEHC NYSE
- TRAW NYSE
- Market Cap
- NEHC 7.5M
- TRAW 7.8M
- IPO Year
- NEHC N/A
- TRAW 2013
- Fundamental
- Price
- NEHC $0.51
- TRAW $1.40
- Analyst Decision
- NEHC
- TRAW
- Analyst Count
- NEHC 0
- TRAW 0
- Target Price
- NEHC N/A
- TRAW N/A
- AVG Volume (30 Days)
- NEHC 14.7M
- TRAW 3.4M
- Earning Date
- NEHC 01-01-0001
- TRAW 08-14-2025
- Dividend Yield
- NEHC N/A
- TRAW N/A
- EPS Growth
- NEHC N/A
- TRAW N/A
- EPS
- NEHC N/A
- TRAW N/A
- Revenue
- NEHC $530,024.00
- TRAW $227,000.00
- Revenue This Year
- NEHC N/A
- TRAW $3.81
- Revenue Next Year
- NEHC N/A
- TRAW $30.43
- P/E Ratio
- NEHC N/A
- TRAW N/A
- Revenue Growth
- NEHC N/A
- TRAW 0.44
- 52 Week Low
- NEHC $0.47
- TRAW $0.97
- 52 Week High
- NEHC $12.29
- TRAW $19.44
- Technical
- Relative Strength Index (RSI)
- NEHC N/A
- TRAW 42.63
- Support Level
- NEHC N/A
- TRAW $1.62
- Resistance Level
- NEHC N/A
- TRAW $1.77
- Average True Range (ATR)
- NEHC 0.00
- TRAW 0.15
- MACD
- NEHC 0.00
- TRAW -0.03
- Stochastic Oscillator
- NEHC 0.00
- TRAW 10.34
About NEHC NEW ERA HELIUM INC
New Era Helium Inc. is an exploration and production company that sources helium produced in association with the production of natural gas reserves in North America. The Company's primary operations include the exploration, development and production of helium, natural gas, oil and natural gas liquids. The Company owns and operates over 137,000 acres in Southeast New Mexico and has over 1.5 billion cubic feet of proved and probable helium reserves. Its producing oil and gas assets and non-producing acreage are located in Chaves County, New Mexico.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.